Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-36.9K
-
Total reported value, excl. options
-
$0
-
Value change
-
-$279K
-
Number of sells
-
-1
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2023
1 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q4 2023.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 37.4M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include WYNNEFIELD CAPITAL INC (4.92M shares), Legion Partners Asset Management, LLC (2.94M shares), Greenhaven Road Investment Management, L.P. (2.37M shares), 22NW, LP (1.76M shares), VANGUARD GROUP INC (1.35M shares), 325 CAPITAL LLC (1.21M shares), Cove Street Capital, LLC (910K shares), MORGAN STANLEY (789K shares), BlackRock Inc. (599K shares), and Visionary Wealth Advisors (497K shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.